Hemodynamic and renal effects of bosentan and losartan in 2k1c hypertensive rats.

Volume 18 , Issue 2 , February 2016 , Pages 63-70

Authors

Sarkawt Hamad 1 ; Ismail Maulood 2

1 Biology Department, Faculty of Science, Soran University, Soran, Iraq

2 Biology Department, College of Science, Salahaddin University, Erbil, Iraq

DOI logo 10.17656/jzs.10504

Keywords

Abstract


Endothelin-1 (ET-1) and Angiotensin II (Ang II) play important roles in generating

hypertension. The present work was investigated the hemodynamic and renal effects of

both ET-1 and Ang II on 2K1C rats. The design of this study included five groups of rats:

Group 1 Sham rats, Group 2 Normotensive rats (2K1C(n)), Group 3 two kidney one clip

hypertensive rats (2K1C(h)), Group 4 two kidney one clip hypertensive rats + Bosentan

(2K1C(h) + Bosentan), and Group 5 two kidney one clip hypertensive rats + Losartan

(2K1C(h) + Losartan). Systolic blood pressure (SBP) was significantly elevated in 2K1C(h)

rats from third to sixth week after surgery compared with control rats. SBP significantly

fell in bosentan and losartan treated rats. Serum nitric oxide (NO) level in hypertensive

rats was slightly decreased, whereas in losartan group it was significantly increased.

Serum malonaldehyde (MDA) significantly increased in bosentan treated rats as

compared to hypertensive rats. Bosentan administration caused a markedly increased in

Na+excretion rate compared with 2K1C(h) rats in week four after surgery. In conclusion,

losartan is more potent than bosentan in reducing hypertension via elevation of serum

NO level.

Statistics
  • Article view374
  • Downloads0
  • Published at18 February 2016

  • RIS
  • BibTeX
  • EndNote
  • Mendeley
  • APA (7th edition)
  • MLA (9th edition)
  • Chicago
  • Harvard
  • IEEE
  • Vancouver